Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology

Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease

document.addEventListener("googletagEvent", function() { googletag.cmd.push(function() { googletag.display('ad-slot_1__mobile'); }); });
Read more on